Discover Baxter International's Q4 2024 earnings insights, including recovery milestones, Novum IQ pump success, and a promising 2025 growth outlook.

Following the completion of a massive restructuring plan, the medical equipment giant projects 4% to 5% sales growth this ...

Three strikes and you’re out? Not for Supernus Pharmaceuticals and its Parkinson’s disease infusion pump. On its fourth attempt to pass muster with the FDA, the company’s SPN-830 ...

DEERFIELD, Ill., February 03, 2025--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that José (Joe) E. Almeida, chair, president and chief ...

Feb 3 (Reuters) - Medical products maker Baxter International (BAX.N), opens new tab said on Monday its CEO José Almeida will retire effective immediately, after nearly a decade as the company's ...

Baxter President and CEO José Almeida has announced his retirement, effective immediately, after nearly a decade of leading the medtech company. The news comes just days after Baxter completed ...

DEERFIELD, Ill., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Vantive, formerly the Baxter Kidney Care segment, today launched as a new standalone vital organ therapy company following the completion of its ...

He will serve in an advisory capacity through Oct. 31, 2025. The Baxter Board of Directors has appointed lead independent director Brent Shafer as chair and interim CEO and has initiated a search ...

Sigma investors would be holding their breath right now. That's because Sigma Healthcare shares are not active on the ASX today. The healthcare stock closed at $3.03 a share yesterday after ...

The announcement drove Sigma shares 7.8 per cent higher in early trade on Tuesday to $2.91. Sigma shareholders are sitting on outsized gains since the proposed merger was announced on December 6 ...